Press Releases

Annual Award to Recognize Innovator Who Is Transforming Society byHelping to Heal, Feed or Fuel the World 

The JOBS Act will incentivize and encourage capital formation for growing companies, and spur job growth in the U.S.  

Today, a group of biofuel and renewable energy organizations released a letter to Congressional leaders asking them to continue to fully support the Renewable Fuel Standard.  

The Biotechnology Industry Organization (BIO) applauds the Senate on the passage of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

“With continuous advances in both biomedical and food applications, we look forward to again bringing together the world’s leading industry, academic and government leaders in the fields of science and animal agriculture.”  

We are excited to bring this conference to Orlando to highlight the industry's growth, particularly in the Southeast region. 

Lobb will lead CBI’s efforts to communicate science-based information about the benefits and safety of agricultural biotechnology and its contributions to sustainable development.

The reauthorization of the Pandemic All-Hazards Preparedness Act and the Special Reserve Fund signify the solid commitment of government attention and funding which will allow the biotech industry to do even more to help protect our nation.

House passes H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

We are excited to offer this information-packed plenary program at the 2012 World Congress where speakers will highlight how industrial biotechnology leads to innovation and new jobs while helping to build a biobased economy.

Global Event for biotechnology to be held June 18-21, 2012 in Boston, MA.

BIO applauded the House Energy and Commerce Committee’s passage of the Medicare Decisions Accountability Act, H.R. 452, which would repeal the Independent Payment Advisory Board (IPAB) established in the health care reform law.

The FAST Act will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases, while preserving the Food and Drug Administration's (FDA) robust standards for safety and effectiveness. 

OncoMed Pharmaceuticals SVP/CFO provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs 

New "Grow It Here, Make It Here" legislation introduced today by Sen. Debbie Stabenow (D-Mich.) would help bio-based manufacturers access vital capital, strengthen market opportunities for biobased products, and spur commercialization of agricultural and industrial biotech innovations.

The Biotechnology Industry Organization (BIO) announced today that it has integrated its alliance development activities into one department as a means of expanding engagement opportunities with external groups that share a commitment to unleashing biotechnology’s capability to benefit patients and consumers.

Member companies of three leading advanced and cellulosic biofuel trade organizations sent a letter to House and Senate leaders asking for extension of the Cellulosic Biofuels Production Tax Credit, which expires December 31, 2012.

Continued commercialization of the industrial biotechnology sector can drive the creation of a biobased economy, which can strengthen the nation’s economic security and enhance energy security. 

BIO thanks Sen. Debbie Stabenow (D-Mich.) for announcing policy proposals in Detroit that will spur commercialization of new agricultural innovations, increase access to capital and create a new tax cut for biobased manufacturers.

BIO submitted a letter to EPA asking that they reject a retroactive reduction of the 2011 Renewable Fuel Standard obligations, requested in January by petroleum refiners.

Company executives, scientists and government officials will bring a global perspective as featured presenters at BIO’s 9th annual World Congress on Biotechnology and Bioprocessing.